Covid 19 Vaccine Trial

CDSCO asks Bharat Biotech to submit complete immunogenicity data of Phase 2 trial of COVID-19 vaccine

The vaccine candidate, 'Covaxin', is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research

COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment

No process in vaccine development trials will be skipped, but approvals to carry out multiple phases of trials parallelly may be given.